Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethyltin-induced cytotoxicity in the mouse hippocampus

► TMT-mediated neurotoxicity is exacerbated by a type I corticosterone receptor (mineralocorticoid receptor) agonist. ► TMT-mediated neurotoxicity is ameliorated by a type I corticosterone receptor (mineralocorticoid receptor) antagonist. ► TMT neurotoxicity is exacerbated by a type II corticosteron...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 2012-03, Vol.511 (2), p.116-119
Hauptverfasser: Ogita, Kiyokazu, Sugiyama, Chie, Acosta, Gabriela Beatriz, Kuramoto, Nobuyuki, Shuto, Makoto, Yoneyama, Masanori, Nakamura, Yukary, Shiba, Tatsuo, Yamaguchi, Taro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 119
container_issue 2
container_start_page 116
container_title Neuroscience letters
container_volume 511
creator Ogita, Kiyokazu
Sugiyama, Chie
Acosta, Gabriela Beatriz
Kuramoto, Nobuyuki
Shuto, Makoto
Yoneyama, Masanori
Nakamura, Yukary
Shiba, Tatsuo
Yamaguchi, Taro
description ► TMT-mediated neurotoxicity is exacerbated by a type I corticosterone receptor (mineralocorticoid receptor) agonist. ► TMT-mediated neurotoxicity is ameliorated by a type I corticosterone receptor (mineralocorticoid receptor) antagonist. ► TMT neurotoxicity is exacerbated by a type II corticosterone (glucocorticoid receptor) antagonist. ► Endogenous corticosterone functions as a multi-regulating factor in TMT-mediated neurotoxicity. The organotin trimethyltin (TMT) is known to cause neuronal degeneration in the murine brain. Earlier studies indicate that TMT-induced neuronal degeneration is enhanced by adrenalectomy and prevented by exogenous glucocorticoid. The aim of this study was to investigate the regulation of TMT neuroxicity by corticosterone receptors including type I (mineralocorticoid receptor, MR) and type II (glucocorticoid receptor, GR) in adult mice. The systemic injection of TMT at the dose of 2.0 or 2.8mg/kg produced a marked elevation in the level of plasma corticosterone that was both dose and time dependent. The MR agonist aldosterone had the ability to exacerbate TMT cytotoxicity in the dentate granule cell layer, whereas its antagonist spironolactone protected neurons from TMT cytotoxicity there. In contrast, the GR antagonist mifepristone exacerbated the TMT cytotoxicity. Taken together, our data suggest TMT cytotoxicity is oppositely regulated by GR and MR signals, being exacerbated by MR activation in adult mice.
doi_str_mv 10.1016/j.neulet.2012.01.052
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_968173907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304394012001218</els_id><sourcerecordid>923953124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-f8d2f7d945f1c2217a95210d84f2862328436df40469a488479fe1a03d3785143</originalsourceid><addsrcrecordid>eNqFkcuO1DAQRS0EYpqBP0DIO1YJ5UfieIOERjxGGmk2sLaCXZ52K7GD7SD6B_hu0vTACg0rL-pUXeseQl4yaBmw_s2hjbhOWFsOjLfAWuj4I7Jjg-KN0oo_JjsQIBuhJVyQZ6UcAKBjnXxKLjgXoJWWO_LzdllSCfGO5jRhocnTu2m1yaZcg03B0YwWl5oyHaOjc4iYx-lf4xBpzWHGuj9ONcQmRLdadNQea6rpR7ChHn9De6RzWgvSfdiy7Tgva3lOnvhxKvji_r0kXz68_3z1qbm5_Xh99e6msR10tfGD4145LTvPLOdMjbrjDNwgPR96LvggRe-8BNnrUQ6DVNojG0E4oYaOSXFJXp_vLjl9W7FUM4dicZrGiNufjO4HpoQG9X-SC90Jxk835Zm0OZWS0Ztl62HMR8PAnFSZgzmrMidVBpjZVG1rr-4D1q8zur9Lf9xswNszgFsh3wNmU2zAuHUattKrcSk8nPALFM-pog</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>923953124</pqid></control><display><type>article</type><title>Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethyltin-induced cytotoxicity in the mouse hippocampus</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ogita, Kiyokazu ; Sugiyama, Chie ; Acosta, Gabriela Beatriz ; Kuramoto, Nobuyuki ; Shuto, Makoto ; Yoneyama, Masanori ; Nakamura, Yukary ; Shiba, Tatsuo ; Yamaguchi, Taro</creator><creatorcontrib>Ogita, Kiyokazu ; Sugiyama, Chie ; Acosta, Gabriela Beatriz ; Kuramoto, Nobuyuki ; Shuto, Makoto ; Yoneyama, Masanori ; Nakamura, Yukary ; Shiba, Tatsuo ; Yamaguchi, Taro</creatorcontrib><description>► TMT-mediated neurotoxicity is exacerbated by a type I corticosterone receptor (mineralocorticoid receptor) agonist. ► TMT-mediated neurotoxicity is ameliorated by a type I corticosterone receptor (mineralocorticoid receptor) antagonist. ► TMT neurotoxicity is exacerbated by a type II corticosterone (glucocorticoid receptor) antagonist. ► Endogenous corticosterone functions as a multi-regulating factor in TMT-mediated neurotoxicity. The organotin trimethyltin (TMT) is known to cause neuronal degeneration in the murine brain. Earlier studies indicate that TMT-induced neuronal degeneration is enhanced by adrenalectomy and prevented by exogenous glucocorticoid. The aim of this study was to investigate the regulation of TMT neuroxicity by corticosterone receptors including type I (mineralocorticoid receptor, MR) and type II (glucocorticoid receptor, GR) in adult mice. The systemic injection of TMT at the dose of 2.0 or 2.8mg/kg produced a marked elevation in the level of plasma corticosterone that was both dose and time dependent. The MR agonist aldosterone had the ability to exacerbate TMT cytotoxicity in the dentate granule cell layer, whereas its antagonist spironolactone protected neurons from TMT cytotoxicity there. In contrast, the GR antagonist mifepristone exacerbated the TMT cytotoxicity. Taken together, our data suggest TMT cytotoxicity is oppositely regulated by GR and MR signals, being exacerbated by MR activation in adult mice.</description><identifier>ISSN: 0304-3940</identifier><identifier>EISSN: 1872-7972</identifier><identifier>DOI: 10.1016/j.neulet.2012.01.052</identifier><identifier>PMID: 22309794</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Aldosterone - pharmacology ; Animals ; Corticosterone - blood ; Glucocorticoid receptor hippocampus ; Hippocampus - drug effects ; Hippocampus - metabolism ; Mice ; Mineralocorticoid receptor ; Mineralocorticoid Receptor Antagonists - pharmacology ; Receptors, Glucocorticoid - metabolism ; Receptors, Glucocorticoid - physiology ; Receptors, Mineralocorticoid - agonists ; Receptors, Mineralocorticoid - metabolism ; Receptors, Mineralocorticoid - physiology ; Spironolactone - pharmacology ; Trimethyltin ; Trimethyltin Compounds - toxicity</subject><ispartof>Neuroscience letters, 2012-03, Vol.511 (2), p.116-119</ispartof><rights>2012 Elsevier Ireland Ltd</rights><rights>Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-f8d2f7d945f1c2217a95210d84f2862328436df40469a488479fe1a03d3785143</citedby><cites>FETCH-LOGICAL-c505t-f8d2f7d945f1c2217a95210d84f2862328436df40469a488479fe1a03d3785143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neulet.2012.01.052$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22309794$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ogita, Kiyokazu</creatorcontrib><creatorcontrib>Sugiyama, Chie</creatorcontrib><creatorcontrib>Acosta, Gabriela Beatriz</creatorcontrib><creatorcontrib>Kuramoto, Nobuyuki</creatorcontrib><creatorcontrib>Shuto, Makoto</creatorcontrib><creatorcontrib>Yoneyama, Masanori</creatorcontrib><creatorcontrib>Nakamura, Yukary</creatorcontrib><creatorcontrib>Shiba, Tatsuo</creatorcontrib><creatorcontrib>Yamaguchi, Taro</creatorcontrib><title>Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethyltin-induced cytotoxicity in the mouse hippocampus</title><title>Neuroscience letters</title><addtitle>Neurosci Lett</addtitle><description>► TMT-mediated neurotoxicity is exacerbated by a type I corticosterone receptor (mineralocorticoid receptor) agonist. ► TMT-mediated neurotoxicity is ameliorated by a type I corticosterone receptor (mineralocorticoid receptor) antagonist. ► TMT neurotoxicity is exacerbated by a type II corticosterone (glucocorticoid receptor) antagonist. ► Endogenous corticosterone functions as a multi-regulating factor in TMT-mediated neurotoxicity. The organotin trimethyltin (TMT) is known to cause neuronal degeneration in the murine brain. Earlier studies indicate that TMT-induced neuronal degeneration is enhanced by adrenalectomy and prevented by exogenous glucocorticoid. The aim of this study was to investigate the regulation of TMT neuroxicity by corticosterone receptors including type I (mineralocorticoid receptor, MR) and type II (glucocorticoid receptor, GR) in adult mice. The systemic injection of TMT at the dose of 2.0 or 2.8mg/kg produced a marked elevation in the level of plasma corticosterone that was both dose and time dependent. The MR agonist aldosterone had the ability to exacerbate TMT cytotoxicity in the dentate granule cell layer, whereas its antagonist spironolactone protected neurons from TMT cytotoxicity there. In contrast, the GR antagonist mifepristone exacerbated the TMT cytotoxicity. Taken together, our data suggest TMT cytotoxicity is oppositely regulated by GR and MR signals, being exacerbated by MR activation in adult mice.</description><subject>Aldosterone - pharmacology</subject><subject>Animals</subject><subject>Corticosterone - blood</subject><subject>Glucocorticoid receptor hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Mice</subject><subject>Mineralocorticoid receptor</subject><subject>Mineralocorticoid Receptor Antagonists - pharmacology</subject><subject>Receptors, Glucocorticoid - metabolism</subject><subject>Receptors, Glucocorticoid - physiology</subject><subject>Receptors, Mineralocorticoid - agonists</subject><subject>Receptors, Mineralocorticoid - metabolism</subject><subject>Receptors, Mineralocorticoid - physiology</subject><subject>Spironolactone - pharmacology</subject><subject>Trimethyltin</subject><subject>Trimethyltin Compounds - toxicity</subject><issn>0304-3940</issn><issn>1872-7972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcuO1DAQRS0EYpqBP0DIO1YJ5UfieIOERjxGGmk2sLaCXZ52K7GD7SD6B_hu0vTACg0rL-pUXeseQl4yaBmw_s2hjbhOWFsOjLfAWuj4I7Jjg-KN0oo_JjsQIBuhJVyQZ6UcAKBjnXxKLjgXoJWWO_LzdllSCfGO5jRhocnTu2m1yaZcg03B0YwWl5oyHaOjc4iYx-lf4xBpzWHGuj9ONcQmRLdadNQea6rpR7ChHn9De6RzWgvSfdiy7Tgva3lOnvhxKvji_r0kXz68_3z1qbm5_Xh99e6msR10tfGD4145LTvPLOdMjbrjDNwgPR96LvggRe-8BNnrUQ6DVNojG0E4oYaOSXFJXp_vLjl9W7FUM4dicZrGiNufjO4HpoQG9X-SC90Jxk835Zm0OZWS0Ztl62HMR8PAnFSZgzmrMidVBpjZVG1rr-4D1q8zur9Lf9xswNszgFsh3wNmU2zAuHUattKrcSk8nPALFM-pog</recordid><startdate>20120309</startdate><enddate>20120309</enddate><creator>Ogita, Kiyokazu</creator><creator>Sugiyama, Chie</creator><creator>Acosta, Gabriela Beatriz</creator><creator>Kuramoto, Nobuyuki</creator><creator>Shuto, Makoto</creator><creator>Yoneyama, Masanori</creator><creator>Nakamura, Yukary</creator><creator>Shiba, Tatsuo</creator><creator>Yamaguchi, Taro</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20120309</creationdate><title>Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethyltin-induced cytotoxicity in the mouse hippocampus</title><author>Ogita, Kiyokazu ; Sugiyama, Chie ; Acosta, Gabriela Beatriz ; Kuramoto, Nobuyuki ; Shuto, Makoto ; Yoneyama, Masanori ; Nakamura, Yukary ; Shiba, Tatsuo ; Yamaguchi, Taro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-f8d2f7d945f1c2217a95210d84f2862328436df40469a488479fe1a03d3785143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aldosterone - pharmacology</topic><topic>Animals</topic><topic>Corticosterone - blood</topic><topic>Glucocorticoid receptor hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Mice</topic><topic>Mineralocorticoid receptor</topic><topic>Mineralocorticoid Receptor Antagonists - pharmacology</topic><topic>Receptors, Glucocorticoid - metabolism</topic><topic>Receptors, Glucocorticoid - physiology</topic><topic>Receptors, Mineralocorticoid - agonists</topic><topic>Receptors, Mineralocorticoid - metabolism</topic><topic>Receptors, Mineralocorticoid - physiology</topic><topic>Spironolactone - pharmacology</topic><topic>Trimethyltin</topic><topic>Trimethyltin Compounds - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ogita, Kiyokazu</creatorcontrib><creatorcontrib>Sugiyama, Chie</creatorcontrib><creatorcontrib>Acosta, Gabriela Beatriz</creatorcontrib><creatorcontrib>Kuramoto, Nobuyuki</creatorcontrib><creatorcontrib>Shuto, Makoto</creatorcontrib><creatorcontrib>Yoneyama, Masanori</creatorcontrib><creatorcontrib>Nakamura, Yukary</creatorcontrib><creatorcontrib>Shiba, Tatsuo</creatorcontrib><creatorcontrib>Yamaguchi, Taro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuroscience letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ogita, Kiyokazu</au><au>Sugiyama, Chie</au><au>Acosta, Gabriela Beatriz</au><au>Kuramoto, Nobuyuki</au><au>Shuto, Makoto</au><au>Yoneyama, Masanori</au><au>Nakamura, Yukary</au><au>Shiba, Tatsuo</au><au>Yamaguchi, Taro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethyltin-induced cytotoxicity in the mouse hippocampus</atitle><jtitle>Neuroscience letters</jtitle><addtitle>Neurosci Lett</addtitle><date>2012-03-09</date><risdate>2012</risdate><volume>511</volume><issue>2</issue><spage>116</spage><epage>119</epage><pages>116-119</pages><issn>0304-3940</issn><eissn>1872-7972</eissn><abstract>► TMT-mediated neurotoxicity is exacerbated by a type I corticosterone receptor (mineralocorticoid receptor) agonist. ► TMT-mediated neurotoxicity is ameliorated by a type I corticosterone receptor (mineralocorticoid receptor) antagonist. ► TMT neurotoxicity is exacerbated by a type II corticosterone (glucocorticoid receptor) antagonist. ► Endogenous corticosterone functions as a multi-regulating factor in TMT-mediated neurotoxicity. The organotin trimethyltin (TMT) is known to cause neuronal degeneration in the murine brain. Earlier studies indicate that TMT-induced neuronal degeneration is enhanced by adrenalectomy and prevented by exogenous glucocorticoid. The aim of this study was to investigate the regulation of TMT neuroxicity by corticosterone receptors including type I (mineralocorticoid receptor, MR) and type II (glucocorticoid receptor, GR) in adult mice. The systemic injection of TMT at the dose of 2.0 or 2.8mg/kg produced a marked elevation in the level of plasma corticosterone that was both dose and time dependent. The MR agonist aldosterone had the ability to exacerbate TMT cytotoxicity in the dentate granule cell layer, whereas its antagonist spironolactone protected neurons from TMT cytotoxicity there. In contrast, the GR antagonist mifepristone exacerbated the TMT cytotoxicity. Taken together, our data suggest TMT cytotoxicity is oppositely regulated by GR and MR signals, being exacerbated by MR activation in adult mice.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>22309794</pmid><doi>10.1016/j.neulet.2012.01.052</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0304-3940
ispartof Neuroscience letters, 2012-03, Vol.511 (2), p.116-119
issn 0304-3940
1872-7972
language eng
recordid cdi_proquest_miscellaneous_968173907
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Aldosterone - pharmacology
Animals
Corticosterone - blood
Glucocorticoid receptor hippocampus
Hippocampus - drug effects
Hippocampus - metabolism
Mice
Mineralocorticoid receptor
Mineralocorticoid Receptor Antagonists - pharmacology
Receptors, Glucocorticoid - metabolism
Receptors, Glucocorticoid - physiology
Receptors, Mineralocorticoid - agonists
Receptors, Mineralocorticoid - metabolism
Receptors, Mineralocorticoid - physiology
Spironolactone - pharmacology
Trimethyltin
Trimethyltin Compounds - toxicity
title Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethyltin-induced cytotoxicity in the mouse hippocampus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A04%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Opposing%20roles%20of%20glucocorticoid%20receptor%20and%20mineralocorticoid%20receptor%20in%20trimethyltin-induced%20cytotoxicity%20in%20the%20mouse%20hippocampus&rft.jtitle=Neuroscience%20letters&rft.au=Ogita,%20Kiyokazu&rft.date=2012-03-09&rft.volume=511&rft.issue=2&rft.spage=116&rft.epage=119&rft.pages=116-119&rft.issn=0304-3940&rft.eissn=1872-7972&rft_id=info:doi/10.1016/j.neulet.2012.01.052&rft_dat=%3Cproquest_cross%3E923953124%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=923953124&rft_id=info:pmid/22309794&rft_els_id=S0304394012001218&rfr_iscdi=true